Kennedy; April L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kennedy; April L..The latest application filed is for "substituted n-(lh-indazol-4-yl)imidazo[l,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors".

Company Profile

1.9.14

Kennedy; April L. - Denver CO
Kennedy; April L. - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 10,669,269 - Boys , et al.	2020-06-02
SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20180086758 - Boys; Mark Laurence ; et al.	2018-03-29
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,809,590 - Boys , et al. November 7, 2	2017-11-07
SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20160002232 - Boys; Mark Laurence ; et al.	2016-01-07
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,174,981 - Boys , et al. November 3, 2	2015-11-03
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Grant 8,841,455 - Boys , et al. September 23, 2	2014-09-23
Substituted N-(1h-indazol-4-yl)imidazo[1,2-]pyridine-3-carboxamide Compounds As Type Iii Receptor Tyrosine Kinase Inhibitors App 20130274244 - Boys; Mark Laurence ; et al.	2013-10-17
Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors App 20120258952 - Boys; Mark Laurence ; et al.	2012-10-11
Peptide inhibitors of hepatitis C virus replication Grant 7,932,277 - Seiwert , et al. April 26, 2	2011-04-26
Inhibitors of hepatitis C virus replication Grant 7,781,474 - Seiwert , et al. August 24, 2	2010-08-24
Novel Inhibitors Of Hepatitis C Virus Replication App 20100209391 - SEIWERT; SCOTT ; et al.	2010-08-19
Novel Peptide Inhibitors Of Hepatitis C Virus Replication App 20090297476 - SEIWERT; SCOTT ; et al.	2009-12-03
Macrocyclic Compounds As Inhibitors Of Viral Replication App 20090286843 - BLATT; LAWRENCE M. ; et al.	2009-11-19
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20090155209 - BLATT; LAWRENCE M. ; et al.	2009-06-18
Macrocyclic Compounds As Inhibitors Of Viral Replication App 20090111969 - Blatt; Lawrence M. ; et al.	2009-04-30
Macrocyclic Compounds As Inhibitors Of Viral Replication App 20090111982 - Blatt; Lawrence M. ; et al.	2009-04-30
Macrocyclic Compounds As Inhibitors Of Viral Replication App 20090105471 - Blatt; Lawrence M. ; et al.	2009-04-23
Macrocyclic compounds as inhibitors of viral replication Grant 7,491,794 - Blatt , et al. February 17, 2	2009-02-17
Novel Inhibitors Of Hepatitis C Virus Replication App 20080019942 - Seiwert; Scott ; et al.	2008-01-24
Macrocyclic compounds as inhibitors of viral replication App 20050267018 - Blatt, Lawrence M. ; et al.	2005-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.